- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01632085
Comparison of Two Laryngoscopes: Single-use Device Laryngobloc ® (SU) Versus Reusable Handle With Disposable Metal Blade (R) (MUUR)
Comparison of Two Laryngoscopes: Single-use Device Laryngobloc ® (SU) Versus Reusable Handle With Disposable Metal Blade (R) : Quality of Laryngoscopy and Bacterial Contamination of the Handle
Study Overview
Status
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alsace
-
Strasbourg cedex, Alsace, France, 67098
- Recruiting
- Hôpitaux universitaires de Strasbourg
-
Sub-Investigator:
- Simone MANGEANT, MD
-
Sub-Investigator:
- Nadia DHIF, MD
-
Sub-Investigator:
- Florin DIMACHE, MD
-
Sub-Investigator:
- Nathalie STOJEBA, MD
-
Sub-Investigator:
- Alice ILIE, MD
-
Sub-Investigator:
- Catherine LEHMANN, MD
-
Sub-Investigator:
- Adriana NASTASIE, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men or women over 18 years·
- Hospitalized for elective surgery and targeted for orotracheal intubation under direct laryngoscopy under general anesthesia with neuromuscular blockade resolved·
- Subject has signed informed consent·
- Suject affiliated to a social protection·
- Subject informed of the results of medical examination
Exclusion Criteria:
- Contraindication to general anesthesia or one of its components·
- General anesthesia without a competitive muscle relaxant·
- Patient with criteria for difficult intubation·
- Patient targeted for special care of the airway (fiberoptic or vidéolaryngoscopy), whatever the indication as Mallampati class 4·
- Subject in class 4 Mallampati·
- Acts performed in the emergency setting·
- Pregnancy and obstetric procedures·
- Breastfeeding·
- Difficulty in communication with the patient (including obtaining informed consent, evaluation of pain in the recovery Room ·
- Subject in exclusion period (determined by a previous study or a study in progress)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Group SU (Single use or Laryngobloc ®) ®)
In order to avoid an order effect, the patient acting as his own control, will randomly undergo a laryngoscopy with each laryngoscopes, the intubation being performed during the second laryngoscopy, here with the Laryngobloc ®.
|
Group SU (Single Use or Laryngobloc ®): the first laryngoscopy is performed with the R and the second laryngoscopy and the intubation is performed with the Laryngobloc ®. Group R (Reusable handle+ disposable metal blade): the first laryngoscopy is performed with the Laryngobloc ® and the second laryngoscopy and the intubation is performed with the R. |
Other: Group R (Reusable handle)
In order to avoid an order effect, the patient acting as his own control, will randomly undergo a laryngoscopy with each laryngoscopes, the intubation being performed during the second laryngoscopy, here with the Disposable Metal Blade.
|
Group SU (Single Use or Laryngobloc ®): the first laryngoscopy is performed with the R and the second laryngoscopy and the intubation is performed with the Laryngobloc ®. Group R (Reusable handle+ disposable metal blade): the first laryngoscopy is performed with the Laryngobloc ® and the second laryngoscopy and the intubation is performed with the R. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The quality of laryngoscopy
Time Frame: 1 year
|
The quality of laryngoscopy.
The quality of the visibility of the glottis, is assessed by the Cormack and Lehane grade.
A rank of 1 or 2 will be considered a success for the analysis of results.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation microbiological and evaluation of intubation
Time Frame: 1 year
|
Evaluation microbiological (bacteria, fungi) and identification of bacteria with smears of the handle of laryngoscopes, the Laryngobloc ® and the reusable battery. Evaluation of intubation: IDS score, satisfaction of the anesthesiologist, intubation time, quality of light offered by the device. |
1 year
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 5131
- 2011-A01548-33 (Other Identifier: ANSM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contamination of the Handles
-
PediatrixCompletedBacterial Contamination Rate of the Cell PhonesUnited States
-
The Hospital for Sick ChildrenCompletedAluminum Contamination of Parenteral NutritionCanada
-
Poitiers University HospitalCompletedIdentification of the Mother or Fetus Contamination by SARS Cov-2 | Research the Presence of Viruses at Different Sites of the Mother and the Fetus or Father | The Survey Builds on a Network Work Already Organized Around the CPDPN of Poitou-Charentes | Analysis Laboratories of the Poitiers...France
-
Denver Health and Hospital AuthorityUniversity of Colorado, DenverCompletedBacterial Contamination of Healthcare Worker UniformsUnited States
-
Dr Riccardo PaceCompletedBlood Contamination of Root Canal During Endodontic TherapyItaly
-
London School of Hygiene and Tropical MedicineUniversity of Zurich; University of Colorado, Boulder; Ministry of Health, Rwanda and other collaboratorsCompletedFaecal Contamination of Household Drinking Water (Environmental Outcome)Rwanda
-
St. Luke's Hospital and Health Network, PennsylvaniaBoehringer IngelheimUnknownEnhance Delineation of the Stomach Anatomy and the Surgeon's Appreciation of the Extent of Gastric Volume to be Removed; | Increase the Safety Profile of the Patient (i.e., Reduce the Likelihood of Accidental Stapling of the Orogastric Tube or Bougie); | Reduce the Incidence of OR... and other conditionsUnited States
-
Dr Riccardo PaceCompletedBlood Contamination of Root Canal During Endodontic Therapy
-
Denver Health and Hospital AuthorityCompleted
-
Haag-Streit AGUniversity Hospital, Basel, SwitzerlandCompletedOptical Biometry of the Human Eye | General Analysis of the Anterior Chamber of the Human EyeSwitzerland
Clinical Trials on The two groups SU and R are defined by the device with which intubation is performed after a first laryngoscopy done with the other device.
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States